/EMOR

EMOR Stock - Healixa Inc.

Q: What is the analyst price target for EMOR?

Analyst price target information is not currently available for EMOR.

Q: What is EMOR's market cap?

Market capitalization information is not currently available for EMOR.

Healthcare|Medical - Healthcare Information Services|OTC

$0.01+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.01

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for EMOR

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

FY2022

FY2023

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.28

52W High$0.06

52W Low$0.01

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$598,885	$8,822	N/A	$59,447	$117,932
Gross Profit	$210,810	$-24,286	$-23,035	$-49,524	$-54,924
Gross Margin	35.2%	-275.3%	N/A	-83.3%	-46.6%
Operating Income	$-6,353,460	$-555,090	$-2,619,240	$-3,073,900	$-1,085,520
Net Income	$-6,730,220	$-645,424	$-2,842,986	$-15,057,567	$-1,106,959
Net Margin	-1123.8%	-7316.1%	N/A	-25329.4%	-938.6%
EPS	$-0.01	$-0.00	$-0.00	$-0.02	$-0.00

Company Overview

Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace. The company was formerly known as Emerald Organic Products Inc. and changed its name to Healixa Inc. in April 2021. The company was founded in 1977 and is based in Holbrook, New York.

Visit Website

Earnings History & Surprises

EMOR

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.00

Q4 2023

EPS Surprise History

Q4 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2023	Dec 31, 2023	—	$-0.00	—	—

Frequently Asked Questions about EMOR

What is EMOR's current stock price?

Healixa Inc. (EMOR) is currently trading at $0.01 per share. The stock has moved +0.00% today.

What is the analyst price target for EMOR?

No analyst price targets are currently available for this stock.

What sector is Healixa Inc. in?

Healixa Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.

What is EMOR's market cap?

Healixa Inc. has a market capitalization of $0.01 billion, making it a small-cap company.

Does EMOR pay dividends?

No, Healixa Inc. does not currently pay a dividend to shareholders.